Abstracts (HTML) List of Authors

Abendroth, A

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone

Aeschbacher, S

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation

Agosti, M

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Aguiriano-Moser, V

The contribution of bile acid transport and endoplasmatic reticulum stress to tissue factor activation in hepatocytes

Akhmedov, A

Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota

Alberio, L

Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Alessi, MC

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection

Alexander, WA

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Aliotta, A

Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk

Allardet-Servent, J

Evolution of platelet phenotype during SARS-CoV-2 infection

Al-Sabbagh, A

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Althaus, K

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Amrane, R

Modelization the impact of antithrombotic agents on pancreatic tumoral micro-environment.
Aggressiveness of breast cancer cells is related with tissue factor expression and procoagulant activity.

Anderle, T

Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia

Andersson, S

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Andreozzi, V

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII

Andresen, F

Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability

Auge, F

Analysis of adherence to therapy comparing DOAC Dipstick test with plasma concentration of rivaroxaban and apixaban in outpatients with venous thromboembolic disease

Auinger, M

Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm

Ay, C

Increased soluble thrombomodulin influences fibrin clot formation in patients with mild to moderate bleeding tendency
Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia

Azar, W

Characterization of rFIX fusion proteins enabling subcutaneous administration